Anixa Biosciences Inc
ANIX
Get informed when a big investor buys or sells
+ FollowMarket Cap$116.36M
Close$
$0.03
99.1% downside
Current Fair Value
99.1% downsideOvervalued by 99.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $116.36 Million |
|---|---|
| Enterprise Value | $115.07 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.34 |
| Beta | 0.6 |
| Outstanding Shares | 33,593,000 |
Return
| Return on Equity | -54.00% |
|---|---|
| Return on Assets | -52.58% |
| Return on Invested Capital | -79.06% |
Valuation & Multiples
| P/E Ratio | -11.46 |
|---|---|
| PEG | 136.7 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -10.89 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 10, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.34%▼ 12.86% |
|---|---|
| Total Invested | $2.20M▼ 83.31% |
| Investors Holding | 13▼ 50.00% |
ESG Score
No data
About Anixa Biosciences Inc
CEO: Amit Kumar